Rockwell Medical, Inc. (NASDAQ:RMTI) Shares Sold by Perkins Capital Management Inc.

Perkins Capital Management Inc. trimmed its holdings in shares of Rockwell Medical, Inc. (NASDAQ:RMTI) by 78.9% in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 73,967 shares of the company’s stock after selling 276,409 shares during the period. Perkins Capital Management Inc.’s holdings in Rockwell Medical were worth $151,000 at the end of the most recent quarter.

Several other large investors have also made changes to their positions in the business. LPL Financial LLC lifted its position in Rockwell Medical by 91.3% during the fourth quarter. LPL Financial LLC now owns 54,872 shares of the company’s stock valued at $112,000 after purchasing an additional 26,191 shares during the period. Raymond James Financial Inc. purchased a new position in shares of Rockwell Medical during the 4th quarter valued at about $28,000. JPMorgan Chase & Co. lifted its holdings in shares of Rockwell Medical by 134,397.1% in the 3rd quarter. JPMorgan Chase & Co. now owns 47,074 shares of the company’s stock valued at $187,000 after buying an additional 47,039 shares during the period. Barclays PLC purchased a new stake in shares of Rockwell Medical in the third quarter worth about $90,000. Finally, XTX Topco Ltd grew its holdings in Rockwell Medical by 45.7% during the third quarter. XTX Topco Ltd now owns 28,455 shares of the company’s stock worth $113,000 after acquiring an additional 8,922 shares during the period. 23.31% of the stock is owned by hedge funds and other institutional investors.

Analyst Upgrades and Downgrades

Several research firms have commented on RMTI. StockNews.com lowered Rockwell Medical from a “buy” rating to a “hold” rating in a research report on Friday, December 20th. HC Wainwright reiterated a “buy” rating and issued a $7.00 target price on shares of Rockwell Medical in a research note on Monday, December 23rd.

Rockwell Medical Stock Performance

Shares of RMTI stock opened at $1.35 on Monday. The company has a current ratio of 2.41, a quick ratio of 2.00 and a debt-to-equity ratio of 0.33. Rockwell Medical, Inc. has a 12-month low of $1.26 and a 12-month high of $5.15. The business’s 50 day moving average is $1.85 and its two-hundred day moving average is $2.60. The company has a market capitalization of $43.63 million, a P/E ratio of -27.00 and a beta of 1.55.

Rockwell Medical (NASDAQ:RMTI) last released its quarterly earnings results on Thursday, March 20th. The company reported ($0.02) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.02 by ($0.04). The company had revenue of $24.67 million during the quarter, compared to analyst estimates of $23.65 million. Rockwell Medical had a negative net margin of 1.25% and a positive return on equity of 8.55%. Analysts expect that Rockwell Medical, Inc. will post 0.03 EPS for the current fiscal year.

Rockwell Medical Company Profile

Rockwell Medical, Inc, together with its subsidiaries, operates as a healthcare company that engages in the development, manufacture, commercialization, and distribution of various hemodialysis products for dialysis providers worldwide. The company offers Triferic Dialysate and Triferic AVNU which are indicated to maintain hemoglobin in adult undergoing hemodialysis.